Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

CME Outfitters

Keeping the Patient in the Center in AMD Care

Access Activity

Overview / Abstract:

Age-related macular degeneration (AMD) is the leading cause of legal blindness in adults over age 50, but the development of agents that target vascular endothelial growth factor (VEGF) has revolutionized its treatment. There are currently two FDA-approved agents (ranibizumab and aflibercept) and one off-label anti-VEGF agent (bevacizumab) being used to treat patients with AMD, and data from emerging anti-VEGF agents have also demonstrated efficacy in improving visual acuity. However, step therapy requirements pose significant barriers to patient access to approved anti-VEGF therapies.

The first part of this CME Outfitters Snack series on overcoming the challenges of prior authorization when treating patients with AMD features expert faculty discussing how to implement patient-centric care models that incorporate shared decision-making, which is imperative to educating patients on the benefits and risks of FDA-approved and off-label agents for the treatment of AMD.

Expiration

Nov 21, 2020

Discipline(s)

Nurse Practitioner , Nursing CNE, Optometry / Ophthalmology CE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

0.5 AMA PRA Category 1 Credit(s)™/contact hours/CEUs

Accreditation

ACCME, ABO, AAPA, ACPE, AANP, RCPSC

Presenters / Authors / Faculty

Darius M. Moshfeghi, MD
Professor and Chief, Retina Division
Horngren Family Vitreoretinal Center
Byers Eye Institute, Department of Ophthalmology
Stanford University School of Medicine
Stanford, CA

Derek van Amerongen, MD, MS
Vice President and Medical Officer
Humana of Ohio
Springdale, OH

Sponsors / Supporters / Grant Providers

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Keywords / Search Terms

CME Outfitters, LLC AMD, age-related macular degeneration, optometry, ophthalmology, eye disease, optical Free CE CME

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.